Patent directory · USPTO A61K / A61P
Patents matching “Agios Pharmaceuticals, Inc.”
93 pharma patents match "Agios Pharmaceuticals, Inc." in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 93 pharmaceutical patents matching "Agios Pharmaceuticals, Inc." in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 10093654
Therapeutically active compounds and their methods of use
granted -
US 10087172
Compounds and their methods of use
granted -
US 10087169
Bicyclic PKM2 activators
granted -
US 10029987
Therapeutic compounds and compositions
granted -
US 10028961
Therapeutically active compounds and their methods of use
granted -
US 10017495
Therapeutically active compounds and their methods of use
granted -
US 10011574
Glutaminase inhibitors and method of use
granted -
US 10000479
Compounds and their methods of use
granted -
US 9982309
Method for treating cell proliferation related disorders
granted -
US 9980961
Pyruvate kinase activators for use in therapy
granted -
US 9968595
Pharmaceutical compositions of therapeutically active compounds
granted -
US 9938259
Therapeutic compositions and related methods of use
granted -
US 9889137
Therapeutically active compounds and their methods of use
granted -
US 9856279
Therapeutically active compositions and their methods of use
granted -
US 9850277
Therapeutically active compositions and their methods of use
granted -
US 9738625
Therapeutically active compounds and their methods of use
granted -
US 9732062
Therapeutically active compounds and their methods of use
granted -
US 9724350
N,6-bis(aryl or heteroaryl)-1,3,5-triazine-2,4-diamine compounds as IDH2 mutants inhibitors for the treatment of cancer
granted -
US 9694013
Therapeutically active compounds and their methods of use
granted -
US 9682080
Pyruvate kinase activators for use in therapy
granted -
US 9662327
Phenyl and pyridinyl substituted piperidines and piperazines as inhibitors of IDH1 mutants and their use in treating cancer
granted -
US 9657004
Pyruvate kinase M2 modulators, therapeutic compositions and related methods of use
granted -
US 9656999
Therapeutically active compounds and their methods of use
granted -
US 9618514
Methods of evaluating patients using E-cadherin and vimentin
granted